![](/img/cover-not-exists.png)
The cardiovascular and platelet effects of epoprostenol (prostacyclin, PGI2) are unaffected by beta-adrenoceptor blockade in man.
S Hassan, H Pickles, A Fish, C Burke, S Warrington, J O'GradyVolume:
14
Year:
1982
Language:
english
DOI:
10.1111/j.1365-2125.1982.tb01993.x
File:
PDF, 1.11 MB
english, 1982